Vontobel

Vontobel is an international investment firm headquartered in Zurich with roots dating back to its founding as a brokerage in Switzerland in 1924. It specializes primarily in wealth management, asset management—including active funds for private and institutional clients—and investment solutions such as structured products. The company operates globally across more than two dozen locations but remains majority-owned by the founding family through direct holdings and a charitable foundation. While it has some exposure to healthcare investments through its asset management business—including funds that invest heavily into healthcare stocks or biotech companies—it does not itself operate as a life science/biotech/pharma/CRO/CDMO company nor does it develop drugs or medical technologies directly. Its role within healthcare is strictly that of an investor or fund manager allocating capital into listed companies within those sectors via specialized funds like the Global Impact Equities Fund or Sectoral Biotech Opportunities Fund I EUR sub-fund managed under Variopartner SICAV umbrella.